Raymond James Financial
ZBH icon

Raymond James Financial’s Zimmer Biomet ZBH Stock Holding History

Raymond James Financial’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$69M Buy
763,201
+47,972
+7% +$4.4M 0.02% 682
2025
Q4 		$64.3M Buy
715,229
+14,758
+2% +$1.4M 0.02% 693
2025
Q3 		$69M Buy
700,471
+51,025
+8% +$5.06M 0.02% 631
2025
Q2 		$59.2M Buy
649,446
+55,349
+9% +$5.35M 0.02% 668
2025
Q1 		$67.2M Buy
594,097
+393,077
+196% +$42.1M 0.03% 580
2024
Q4 		$21.2M Buy
+201,020
New +$21.6M 0.01% 1265

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raymond James Financial's ZBH Position: Q1 2026 in Review

Raymond James Financial increased its Zimmer Biomet (ZBH) stake by 6.7% in Q1 2026, buying an estimated $4.4M and bringing the position to 763,201 shares worth $69M. The position accounts for 0.02% of the portfolio, ranked #682.

Raymond James Financial first reported a position in ZBH in Q4 2024 and has held it in 6 quarters since. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Raymond James Financial held 763,201 shares of Zimmer Biomet worth $69M as of Q1 2026.
  • Raymond James Financial bought 47,972 Zimmer Biomet shares in Q1 2026, an estimated $4.4M.
  • Zimmer Biomet made up 0.02% of Raymond James Financial's portfolio in Q1 2026, its #682 holding.
  • Raymond James Financial first reported a position in Zimmer Biomet in Q4 2024 and has held it in 6 quarters since.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.